drugset / Trial / NCT06066645
Travoprost Intraocular Implant + iStent Infinite
RandomizedParallel-groupDouble-blindTreatment
Summary
Adult subjects with elevated intraocular pressure will be randomized to receive iStent infinite trabecular bypass system plus a travoprost intraocular implant or receive a sham procedure plus a travoprost intraocular implant and be followed for 12 months.
Timeline
- Start
- 2023-09-14
- Primary completion
- 2027-05
- Completion
- 2028-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Travoprost | Other / unclassified | — | Other |